Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Treatment for Syndromes of Dementia and Movement Disorders market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Treatment for Syndromes of Dementia and Movement Disordersmarket, defines the market attractiveness level of Treatment for Syndromes of Dementia and Movement Disorders market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Treatment for Syndromes of Dementia and Movement Disorders industry, describes the types of Treatment for Syndromes of Dementia and Movement Disorders market, the applications of major players and the market size, and deeply analyzes the current situation of the global Treatment for Syndromes of Dementia and Movement Disorders market and the development prospects and opportunities of Treatment for Syndromes of Dementia and Movement Disorders industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Treatment for Syndromes of Dementia and Movement Disorders market in Chapter 13.
By Player:
AstraZeneca GmbH
Bristol-Myers Squibb
F Hoffmann-La Roche
Valeant Pharmaceutical International
Baxter International
Sanofi
Novartis
Abbott Laboratories
Pfizer
Merck
By Type:
Movement Disorders
Progressive Dementia
Progressive Dementia with Neurological Abnormality (PDNA)
By End-User:
Below 70 Years Old
Above 70 Years Old
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Treatment for Syndromes of Dementia and Movement Disorders Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Treatment for Syndromes of Dementia and Movement Disorders Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Treatment for Syndromes of Dementia and Movement Disorders Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Treatment for Syndromes of Dementia and Movement Disorders Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Treatment for Syndromes of Dementia and Movement Disorders Market Analysis and Outlook to 2022
-
7.1 Global Treatment for Syndromes of Dementia and Movement Disorders Consumption (2017-2022)
-
7.2 United States Treatment for Syndromes of Dementia and Movement Disorders Consumption (2017-2022)
-
7.3 Europe Treatment for Syndromes of Dementia and Movement Disorders Consumption (2017-2022)
-
7.4 China Treatment for Syndromes of Dementia and Movement Disorders Consumption (2017-2022)
-
7.5 Japan Treatment for Syndromes of Dementia and Movement Disorders Consumption (2017-2022)
-
7.6 India Treatment for Syndromes of Dementia and Movement Disorders Consumption (2017-2022)
-
7.7 South Korea Treatment for Syndromes of Dementia and Movement Disorders Consumption (2017-2022)
8 Region and Country-wise Treatment for Syndromes of Dementia and Movement Disorders Market Analysis and Outlook to 2028
-
8.1 Global Treatment for Syndromes of Dementia and Movement Disorders Consumption Forecast (2022-2028)
-
8.2 United States Treatment for Syndromes of Dementia and Movement Disorders Consumption Forecast (2022-2028)
-
8.3 Europe Treatment for Syndromes of Dementia and Movement Disorders Consumption Forecast (2022-2028)
-
8.4 China Treatment for Syndromes of Dementia and Movement Disorders Consumption Forecast (2022-2028)
-
8.5 Japan Treatment for Syndromes of Dementia and Movement Disorders Consumption Forecast (2022-2028)
-
8.6 India Treatment for Syndromes of Dementia and Movement Disorders Consumption Forecast (2022-2028)
-
8.7 South Korea Treatment for Syndromes of Dementia and Movement Disorders Consumption Forecast (2022-2028)
9 Global Treatment for Syndromes of Dementia and Movement Disorders Market Outlook by Types and Applications to 2022
-
9.1 Global Treatment for Syndromes of Dementia and Movement Disorders Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Movement Disorders Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Progressive Dementia Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Progressive Dementia with Neurological Abnormality (PDNA) Consumption and Growth Rate (2017-2022)
-
9.2 Global Treatment for Syndromes of Dementia and Movement Disorders Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Below 70 Years Old Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Above 70 Years Old Consumption and Growth Rate (2017-2022)
10 Global Treatment for Syndromes of Dementia and Movement Disorders Market Outlook by Types and Applications to 2028
-
10.1 Global Treatment for Syndromes of Dementia and Movement Disorders Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Movement Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Progressive Dementia Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Progressive Dementia with Neurological Abnormality (PDNA) Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Treatment for Syndromes of Dementia and Movement Disorders Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Below 70 Years Old Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Above 70 Years Old Consumption Forecast and Growth Rate (2022-2028)
11 Global Treatment for Syndromes of Dementia and Movement Disorders Import and Export Analysis (Top 5 Countries)
-
11.1 Global Treatment for Syndromes of Dementia and Movement Disorders Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Treatment for Syndromes of Dementia and Movement Disorders Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Treatment for Syndromes of Dementia and Movement Disorders Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Treatment for Syndromes of Dementia and Movement Disorders Market Competitive Analysis
-
14.1 AstraZeneca GmbH
-
14.1.1 AstraZeneca GmbH Company Details
-
14.1.2 AstraZeneca GmbH Treatment for Syndromes of Dementia and Movement Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AstraZeneca GmbH Treatment for Syndromes of Dementia and Movement Disorders Product and Service
-
14.2 Bristol-Myers Squibb
-
14.2.1 Bristol-Myers Squibb Company Details
-
14.2.2 Bristol-Myers Squibb Treatment for Syndromes of Dementia and Movement Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bristol-Myers Squibb Treatment for Syndromes of Dementia and Movement Disorders Product and Service
-
14.3 F Hoffmann-La Roche
-
14.3.1 F Hoffmann-La Roche Company Details
-
14.3.2 F Hoffmann-La Roche Treatment for Syndromes of Dementia and Movement Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 F Hoffmann-La Roche Treatment for Syndromes of Dementia and Movement Disorders Product and Service
-
14.4 Valeant Pharmaceutical International
-
14.4.1 Valeant Pharmaceutical International Company Details
-
14.4.2 Valeant Pharmaceutical International Treatment for Syndromes of Dementia and Movement Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Valeant Pharmaceutical International Treatment for Syndromes of Dementia and Movement Disorders Product and Service
-
14.5 Baxter International
-
14.5.1 Baxter International Company Details
-
14.5.2 Baxter International Treatment for Syndromes of Dementia and Movement Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Baxter International Treatment for Syndromes of Dementia and Movement Disorders Product and Service
-
14.6 Sanofi
-
14.6.1 Sanofi Company Details
-
14.6.2 Sanofi Treatment for Syndromes of Dementia and Movement Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Sanofi Treatment for Syndromes of Dementia and Movement Disorders Product and Service
-
14.7 Novartis
-
14.7.1 Novartis Company Details
-
14.7.2 Novartis Treatment for Syndromes of Dementia and Movement Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novartis Treatment for Syndromes of Dementia and Movement Disorders Product and Service
-
14.8 Abbott Laboratories
-
14.8.1 Abbott Laboratories Company Details
-
14.8.2 Abbott Laboratories Treatment for Syndromes of Dementia and Movement Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Abbott Laboratories Treatment for Syndromes of Dementia and Movement Disorders Product and Service
-
14.9 Pfizer
-
14.9.1 Pfizer Company Details
-
14.9.2 Pfizer Treatment for Syndromes of Dementia and Movement Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Pfizer Treatment for Syndromes of Dementia and Movement Disorders Product and Service
-
14.10 Merck
-
14.10.1 Merck Company Details
-
14.10.2 Merck Treatment for Syndromes of Dementia and Movement Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Merck Treatment for Syndromes of Dementia and Movement Disorders Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Treatment for Syndromes of Dementia and Movement Disorders
-
Figure Treatment for Syndromes of Dementia and Movement Disorders Picture
-
Table Global Treatment for Syndromes of Dementia and Movement Disorders Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Treatment for Syndromes of Dementia and Movement Disorders Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Treatment for Syndromes of Dementia and Movement Disorders Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Treatment for Syndromes of Dementia and Movement Disorders Consumption by Country (2017-2022)
-
Figure United States Treatment for Syndromes of Dementia and Movement Disorders Consumption and Growth Rate (2017-2022)
-
Table Europe Treatment for Syndromes of Dementia and Movement Disorders Consumption and Growth Rate (2017-2022)
-
Figure China Treatment for Syndromes of Dementia and Movement Disorders Consumption and Growth Rate (2017-2022)
-
Figure Japan Treatment for Syndromes of Dementia and Movement Disorders Consumption and Growth Rate (2017-2022)
-
Figure India Treatment for Syndromes of Dementia and Movement Disorders Consumption and Growth Rate (2017-2022)
-
Figure South Korea Treatment for Syndromes of Dementia and Movement Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Treatment for Syndromes of Dementia and Movement Disorders Consumption Forecast by Country (2022-2028)
-
Figure United States Treatment for Syndromes of Dementia and Movement Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Treatment for Syndromes of Dementia and Movement Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Treatment for Syndromes of Dementia and Movement Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Treatment for Syndromes of Dementia and Movement Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Treatment for Syndromes of Dementia and Movement Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Treatment for Syndromes of Dementia and Movement Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Movement Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Progressive Dementia Consumption and Growth Rate (2017-2022)
-
Figure Global Progressive Dementia with Neurological Abnormality (PDNA) Consumption and Growth Rate (2017-2022)
-
Figure Global Below 70 Years Old Consumption and Growth Rate (2017-2022)
-
Figure Global Above 70 Years Old Consumption and Growth Rate (2017-2022)
-
Figure Global Movement Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Progressive Dementia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Progressive Dementia with Neurological Abnormality (PDNA) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Below 70 Years Old Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Above 70 Years Old Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Treatment for Syndromes of Dementia and Movement Disorders Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Treatment for Syndromes of Dementia and Movement Disorders Export by Region (Top 5 Countries) (2017-2028)
-
Table AstraZeneca GmbH (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca GmbH Treatment for Syndromes of Dementia and Movement Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca GmbH Treatment for Syndromes of Dementia and Movement Disorders Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Treatment for Syndromes of Dementia and Movement Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Treatment for Syndromes of Dementia and Movement Disorders Product and Service
-
Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Treatment for Syndromes of Dementia and Movement Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Treatment for Syndromes of Dementia and Movement Disorders Product and Service
-
Table Valeant Pharmaceutical International (Foundation Year, Company Profile and etc.)
-
Table Valeant Pharmaceutical International Treatment for Syndromes of Dementia and Movement Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Pharmaceutical International Treatment for Syndromes of Dementia and Movement Disorders Product and Service
-
Table Baxter International (Foundation Year, Company Profile and etc.)
-
Table Baxter International Treatment for Syndromes of Dementia and Movement Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter International Treatment for Syndromes of Dementia and Movement Disorders Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Treatment for Syndromes of Dementia and Movement Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Treatment for Syndromes of Dementia and Movement Disorders Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Treatment for Syndromes of Dementia and Movement Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Treatment for Syndromes of Dementia and Movement Disorders Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Treatment for Syndromes of Dementia and Movement Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Treatment for Syndromes of Dementia and Movement Disorders Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Treatment for Syndromes of Dementia and Movement Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Treatment for Syndromes of Dementia and Movement Disorders Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Treatment for Syndromes of Dementia and Movement Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Treatment for Syndromes of Dementia and Movement Disorders Product and Service
-
